Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
Washington University School of Medicine
Eisai Inc.
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Sonnet BioTherapeutics
City of Hope Medical Center
Baylor College of Medicine
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Boundless Bio, Inc.
Baylor College of Medicine
University of Southern California
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Massachusetts General Hospital
University Health Network, Toronto
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
City of Hope Medical Center
University of Iowa
M.D. Anderson Cancer Center
Amgen
M.D. Anderson Cancer Center
University of Alabama at Birmingham
University of Nebraska
OHSU Knight Cancer Institute
Valo Therapeutics Oy
University of Alabama at Birmingham
Institut Claudius Regaud
Baylor College of Medicine
Eli Lilly and Company
Jonsson Comprehensive Cancer Center
Agenus Inc.
Nkarta, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
M.D. Anderson Cancer Center
Philogen S.p.A.
Adaptimmune